--- page 1 ---
1
Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the “ Stock Exchange ”) and Hong
Kong Securities Clearing Company Limited (“ HKSCC”) take no responsibility for the contents of this announcement, make no
representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising
from or in reliance upon the whole or any part of the contents of this announcement.
Unless otherwise defined herein, capitalized terms used in this announcement shall have the same meanings as those defined
in the prospectus dated December 15, 2025 (the “ Prospectus”) issued by QingSong Health Corporation ( 輕松健康集團 ) (the
“Company”).
This announcement is for information purposes only and does not constitute an offer or an invitation to induce an offer by any
person to acquire, purchase or subscribe for any securities of the Company. This announcement is not a prospectus. Potential
investors should read the Prospectus for detailed information about the Company and the Global Offering described below before
deciding whether or not to invest in the Offer Shares. Any investment decision in relation to the Offer Shares should be taken
solely in reliance on the information provided in the Prospectus.
This announcement is not for release, publication, distribution, directly or indirectly, in or into the United States (including its
territories and possessions, any state of the United States and the District of Columbia). This announcement does not, and is not
intended to, constitute or form a part of any offer to sell or solicitation to purchase or subscribe for any securities in the United
States or in any other jurisdiction. The Offer Shares have not been, and will not be, registered under the United States Securities
Act of 1933, as amended from time to time (the “ U.S. Securities Act ”) or securities law of any state or other jurisdiction of
the United States and may not be offered, sold, pledged or otherwise transferred within the United States, except pursuant to
an available exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and in
compliance with any applicable state securities laws. The Offer Shares are being offered and sold solely outside the United States
in offshore transactions in reliance on Regulation S under the U.S. Securities Act and applicable laws of each jurisdiction where
those offers and sales occur. There will be no public offer of the Offer Shares in the United States.
In connection with the Global Offering, China International Capital Corporation Hong Kong Securities Limited, as stabilizing
manager (the “ Stabilizing Manager ”) (or its affiliates or any person acting for it), on behalf of the Underwriters, to the
extent permitted by the applicable laws and regulatory requirements of Hong Kong or elsewhere, may over-allocate or effect
transactions with a view to stabilizing or supporting the market price of the Shares at such price, in such amounts and in such
manners as the Stabilizing Manager, its affiliates or any person acting for it may determine and at a level higher than that which
might otherwise prevail for a limited period after the Listing Date. However, there is no obligation on the Stabilizing Manager
(or its affiliates or any person acting for it) to conduct any such stabilizing action. Such stabilizing action, if taken, (a) will be
conducted at the absolute discretion of the Stabilizing Manager (or its affiliates or any person acting for it) and in what the
Stabilizing Manager reasonably regards as the best interest of the Company, (b) may be discontinued at any time and (c) is
required to be brought to an end within 30 days of the last day for lodging applications under the Hong Kong Public Offering
(which is Saturday, January 17, 2026). Such stabilizing action, if taken, may be effected in all jurisdictions where it is permissible
to do so, in each case in compliance with all applicable laws, rules and regulatory requirements, including the Securities and
Futures (Price Stabilizing) Rules (Chapter 571W of the Laws of Hong Kong), as amended, made under the Securities and Futures
Ordinance (Chapter 571 of the Laws of Hong Kong).
Potential investors should be aware that no stabilizing action can be taken to support the price of the Shares for longer than the
stabilization period, which will begin on the Listing Date, and is expected to expire on the 30th day after the last day for lodging
applications under the Hong Kong Public Offering (which is Saturday, January 17, 2026). After this date, when no further
stabilizing action may be taken, demand for the Shares, and therefore the price of the Shares, could fall.
In connection with the Global Offering, China International Capital Corporation Hong Kong Securities Limited and China
Merchants Securities (HK) Co., Limited act as the Joint Sponsors and Overall Coordinators.
Potential investors of the Offer Shares should note that the Overall Coordinators (for themselves and on behalf of the Hong Kong
Underwriters) shall be entitled to terminate the Hong Kong Underwriting Agreement with immediate effect upon the occurrence
of any of the events set out in the section headed “Underwriting — Hong Kong Underwriting Arrangements — Hong Kong Public
Offering — Grounds for Termination” in the Prospectus at any time prior to 8:00 a.m. (Hong Kong time) on the Listing Date
(which is currently expected to be on Tuesday, December 23, 2025).
The Overall Coordinators confirm that there has been no over-allocation of the Shares under the International Offering.
Therefore, the Stock Borrowing Agreement will not be entered into and the Over-allotment Option will not be exercised. In view
of the fact that there has been no over-allocation of the Shares under the International Placing, no stabilising action as described
in the Prospectus will be taken during the stabilisation period.


--- page 2 ---
2
QingSong Health Corporation
輕松健康集團
(Incorporated in the Cayman Islands with limited liability)
GLOBAL OFFERING
Total number of Offer Shares under
the Global Offering
: 26,540,000 Shares
Number of Hong Kong Offer Shares : 2,654,000 Shares
Number of International Offer Shares : 23,886,000 Shares
Offer Price : HK$22.68 per Share, plus brokerage of
1.0%, SFC transaction levy of 0.0027%,
the Stock Exchange trading fee of 0.00565%
and AFRC transaction levy of 0.00015%
Nominal value : US$0.0001 per Share
Stock code : 2661
Joint Sponsors, Overall Coordinators, Joint Global Coordinators,
Joint Bookrunners and Joint Lead Managers
Joint Global Coordinator, Joint Bookrunner and Joint Lead Manager
Joint Bookrunner and Joint Lead Manager


--- page 3 ---
3
QINGSONG HEALTH CORPORATION 輕松健康集團
ANNOUNCEMENT OF ALLOTMENT RESULTS
Unless otherwise defined herein, capitalized terms used in this announcement shall have the same
meanings as those defined in the prospectus dated December 15, 2025 (the “ Prospectus”) issued by
QingSong Health Corporation ( 輕松健康集團 ) (the “ Company”).
Warning: In view of high concentration of shareholding in a small number of Shareholders,
Shareholders and prospective investors should be aware that the price of the Shares could
move substantially even with a small number of Shares traded and should exercise extreme
caution when dealing in the Shares.
SUMMARY
Company information
Stock code 2661
Stock short name QINGSONG HEALTH
Dealings commencement date December 23, 2025*
* see note at the end of the announcement
Price Information
Offer Price HK$22.68
Offer Shares and Share Capital
Total number of Offer Shares 26,540,000 Shares
Number of Offer Shares in Hong Kong Public Offering 2,654,000 Shares
Number of Offer Shares in International Offering 23,886,000 Shares
Number of issued Shares upon Listing 206,374,209 Shares
Over-allocation
No. of Offer Shares over-allocated 0
Note:  There has been no over-allocation of Offer Shares in the International Placing. Therefore, the Over-allotment Option
will not be exercised.
Proceeds
Gross proceeds (Note) HK$601.93 million
  Less: Estimated listing expenses payable based on Offer Price HK$88.50 million
Net proceeds HK$513.42 million
Note: Gross proceeds refer to the amount to which the issuer is entitled to receive. For details of the use of proceeds, please
refer to the section headed “Future Plans and Use of Proceeds” of the Prospectus.


--- page 4 ---
4
ALLOTMENT RESULTS DETAILS
HONG KONG PUBLIC OFFERING
No. of valid applications 111,894
No. of successful applications 12,338
Subscription level 1,421.47 times
Reallocation 0
No. of Offer Shares initially available under the Hong Kong Public
Offering
2,654,000
No. of Offer Shares reallocated from the International Offering 0
Final no. of Offer Shares under the Hong Kong Public Offering 2,654,000
% of final no. of Offer Shares under the Hong Kong Public Offering
to the Global Offering
10%
Note:  For details of the final allocation of Shares to the Hong Kong Public Offering, investors can refer to
www.eipo.com.hk/eIPOAllotment  to perform a search by identification number or www.eipo.com.hk/eIPOAllotment  for the
full list of allottees.
INTERNATIONAL OFFERING
No. of placees 113
Subscription Level 2.9 times
No. of Offer Shares initially available under the International
Offering
23,886,000
No. of Offer Shares reallocated to the Hong Kong Public Offering 0
Final no. of Offer Shares under the International Offering 23,886,000
% of final no. of Offer Shares under the International Offering to
the Global Offering
90%
The Directors confirm that, to the best of their knowledge, information and belief, save for a
consent under Chapter 4.15 of the Guide for New Listing Applicants to permit the Company to,
among other things, allocate further Shares in the International Offering to certain Cornerstone
investor and/or their respective close associates, (i) none of the Offer Shares subscribed by the
placees and the public have been financed directly or indirectly by the Company, any of the
Directors, chief executive of the Company, Controlling Shareholders, substantial Shareholders,
existing Shareholders of the Company or any of its subsidiaries or their respective close associates;
(ii) no rebate has been, directly or indirectly, provided by the Company, the Directors, chief
executive of the Company, Controlling Shareholders, substantial Shareholders of the Company,
existing Shareholders of the Company or any of their subsidiaries or their respective close
associates or syndicate members to any public Shareholders in the Hong Kong Public Offering or
placees in the International Offering; (iii) the consideration payable by the public Shareholders


--- page 5 ---
5
in the Hong Kong Public Offering and placees in the International Offering for each Share
subscribed for or purchased by them is the same as the Offer Price as determined by the Company,
in additional to brokerage of 1.0%, SFC transaction levy of 0.0027%, AFRC transaction levy
of 0.00015% and Stock Exchange trading fee of 0.00565%; (iv) there is no side agreement
or arrangement between the Company, any of the Directors, chief executive of the Company,
Controlling Shareholders, substantial Shareholders of the Company, existing Shareholders of
the Company or any of their subsidiaries or their respective close associates, on one hand, and
the public subscribers or the placee who has subscribed for the Offer Shares, on the other hand;
and (v) none of the placees and the public who have purchased the Offer Shares are accustomed
to taking instructions from the Company, any of the Directors, chief executive of the Company,
Controlling Shareholders, substantial Shareholders, existing Shareholders of the Company or any
of its subsidiaries or their respective close associates in relation to the acquisition, disposal, voting
or other disposition of Shares registered in his/her/its name or otherwise held by him/her/it.
The placees in the International Offering include the following:
Allottee with Consent Obtained
Investor
No. of
Offer
Shares
allocated
% of
Offer Shares
% of
total issued
Shares after
the Global
Offering
% of
total issued
Shares after
the Global
Offering
Note 1
Relationship
Allotees with consent under paragraph 1C(1) of the Placing Guidelines and Chapter 4.15 of the
Guide for New Listing Applicants in relation to allocations to connected clients
Note 2
Guangdong-Macao In-Depth
Cooperation Zone In Hengqin
Aoqin Heming Investment
Partnership (Limited Partnership)
(“Aoqin Heming ”)
4,801,800 18.09% 2.33% Connected
client
Bosera Asset Management
(International) Co., Limited
(“Bosera AM ”)
8,400 0.03% 0.004% Connected
client
Notes:
1. The Over-allotment Option is not exercised.
2. For details of the consent under paragraph 1C(1) of the Placing Guidelines and Chapter 4.15
of the Guide for New Listing Applicants in relation to allocations to connected clients, please
refer to the section headed “Others/Additional Information – Placing to connected clients with
prior consents under paragraph 1C(1) of the Placing Guidelines” in this announcement.


--- page 6 ---
6
Cornerstone Investor
Investor
Note 1
No. of
Offer Shares
allocated
% of
Offer Shares
% of
total issued
Shares after
the Global
Offering
Existing
shareholders
or their close
associates
Aoqin Heming 4,801,800 18.09% 2.33% No
Note:
1. For further details of the Cornerstone Investor, please refer to the section headed
“Cornerstone Investor” in the Prospectus.
LOCK-UP UNDERTAKINGS
Controlling Shareholders
Name
Number of Shares held
in the Company subject
to lock-up undertakings
upon Listing
% of shareholding in
the Company subject to
lock-up undertakings
upon Listing
Last day subject to the
lock-up undertakings
Ms. Yang
Note 1
74,322,116 36.01% June 23, 2026
Note 2
 (First
Six-Month Period)
December 23, 2026
Note 3
(Second Six-Month
Period)
Clematis Holding
Limited
Note 1
43,038,800 20.85% June 23, 2026
Note 2
 (First
Six-Month Period)
December 23, 2026
Note 3
(Second Six-Month
Period)
Vlove Holdings
Limited
Note 1
43,038,800 20.85% June 23, 2026
Note 2
 (First
Six-Month Period)
December 23, 2026
Note 3
(Second Six-Month
Period)
QingSongChou
Holdings
Corporation
 Note 1
43,038,800 20.85% June 23, 2026
Note 2
(First
Six-Month Period)
December 23, 2026
Note 3
 (Second Six-Month
Period)


--- page 7 ---
7
Name
Number of Shares held
in the Company subject
to lock-up undertakings
upon Listing
% of shareholding in
the Company subject to
lock-up undertakings
upon Listing
Last day subject to the
lock-up undertakings
QSC ESO
Limited
Note 1
43,038,800 20.85% June 23, 2026
Note 2
(First
Six-Month Period)
December 23, 2026
Note 3
 (Second Six-Month
Period)
Total 74,322,116 36.01%
Notes:
1. As of the latest Practicable Date, QingSongChou Holdings Corporation is a holding company
owned as to 1% by Clematis Holding Limited, which is wholly-owned by Ms. Yang, and 99%
by Vlove Holdings Limited, a nominee company wholly-controlled by Ms. Yang through her
family trust, Vlove Holdings Trust. QSC ESO Limited is a holding company controlled by
Ms. Yang as to 100% through certain voting proxy arrangement between Ms. Yang and the
shareholders of QSC ESO Limited.
2. In accordance with the relevant Listing Rule/guidance materials, the required lock-up for the
date that is six months after the Listing Date (the “First Six-Month Period”) ends on June 23,
2026. A Controlling Shareholder may dispose of or transfer Shares after the indicated date
provided that such Controlling Shareholder will not cease to be a Controlling Shareholder.
3. In accordance with the relevant Listing Rule/guidance materials, the required lock-up for the
period of six months commencing on the date on which the First Six-Month Period expires (the
“Second Six-Month Period”) ends on December 23, 2026.
Existing Shareholders (Including the Pre-IPO Investors as defined in the “History and Corporate
Structure” section of the Prospectus but excluding the Controlling Shareholders)
Name
Number of Shares held
in the Company subject
to lock-up undertakings
upon Listing
% of shareholding in
the Company subject to
lock-up undertakings
upon Listing
Last day subject to the
lock-up undertakings
WIND
ENTERPRISE
LIMITED
9,117,190 4.42% June 30, 2026
Note 1
Universal Light
Limited
6,862,366 3.33% June 30, 2026
Note 1
Grand Path
Ventures Limited
13,427,042 6.51% June 30, 2026
Note 1
IDG China Media
Fund II L.P.
23,176,100 11.23% June 30, 2026
Note 1


--- page 8 ---
8
Name
Number of Shares held
in the Company subject
to lock-up undertakings
upon Listing
% of shareholding in
the Company subject to
lock-up undertakings
upon Listing
Last day subject to the
lock-up undertakings
IDG China
Capital Fund III
L.P.
8,017,106 3.88% June 30, 2026
Note 1
IDG China
Capital III
Investors L.P.
710,421 0.34% June 30, 2026
Note 1
Sunshine Life
Insurance
Corporation
Limited
18,995,124 9.20% June 30, 2026
Note 1
DT Global
Consumer
Investment
Company Limited
15,408,850 7.47% June 30, 2026
Note 1
TDH Venture
Capital
Investment
Limited
12,778,782 6.19% June 30, 2026
Note 1
Genesis Premium
Holdings Limited
9,497,562 4.60% June 30, 2026
Note 1
Under Light
Holding Limited
9,117,190 4.42% June 30, 2026
Note 1
CE FINTECH
I LIMITED
PARTNERSHIP
2,825,543 1.37% June 30, 2026
Note 1
Chinese Rose
Investment
Limited
1,636,410 0.79% June 30, 2026
Note 1
Ricedonate
Network
Technology
Limited
916,233 0.44% June 30, 2026
Note 1
Total 132,485,919 64.19%
Note:
1. The expiry date of the lock-up period shown in the table above is pursuant to voluntary
undertaking.


--- page 9 ---
9
Cornerstone Investor
Name
Number of Shares
held in the Company
subject to lock-up
undertakings upon
Listing
% of shareholding in
the Company subject to
lock-up undertakings
upon Listing
Last day subject to the
lock-up undertakings
Aoqin Heming 4,801,800 2.33% June 30, 2026
Note 1
Total 4,801,800 2.33%
Note:
1. The expiry date of the lock-up period shown in the table above is pursuant to voluntary
undertaking.
PLACEE CONCENTRATION ANALYSIS
Placees*
Number of
Shares allotted
Allotment as %
of International
Offering
Allotment as %
of total Offer
Shares
Number of
Shares held
upon Listing
% of total
issued Shares
upon Listing
Top 1 4,801,800 20.10% 18.09% 4,801,800 2.33%
Top 5 9,379,200 39.27% 35.34% 9,379,200 4.54%
Top 10 13,788,200 57.73% 51.95% 13,788,200 6.68%
Top 25 22,512,400 94.25% 84.82% 22,512,400 10.91%
Note
* Ranking of placees is based on the number of Shares allotted to the placees.


--- page 10 ---
10
SHAREHOLDER CONCENTRATION ANALYSIS
Shareholders*
Number of
Shares allotted
Allotment as %
of International
Offering
Allotment as %
of total Offer
Shares
Number of
Shares held
upon Listing
% of total
issued Shares
upon Listing
Top 1 0 0% 0% 47,348,290
#
22.94%
Top 5 0 0% 0% 127,082,933 61.58%
Top 10 0 0% 0% 174,456,023 84.53%
Top 25 15,551,800 65.11% 58.60% 195,386,009 94.68%
Note
* Ranking of Shareholders is based on the number of Shares (of all classes) held by the
Shareholder upon Listing.
# The Shares herein representing the interest in the controlled corporation held by Ms. Yang Yin,
namely QingSongChou Holdings Corporation and QSC ESO Limited.
BASIS OF ALLOCATION UNDER THE HONG KONG PUBLIC OFFERING
Subject to the satisfaction of the conditions set out in the Prospectus, a total of 111,894 valid
applications made by the public will be conditionally allocated on the basis set out below:
NO. OF SHARES
APPLIED FOR
NO. OF VALID
APPLICATIONS BASIS OF ALLOTMENT/BALLOT
APPROXIMATE
PERCENTAGE
ALLOTTED OF
THE TOTAL
NO. OF SHARES
APPLIED FOR
POOL A
200 34,540 2,072 out of 34,540 to receive 200 Shares 6.00%
400 17,846 1,086 out of 17,846 to receive 200 Shares 3.04%
600 3,549 216 out of 3,549 to receive 200 Shares 2.03%
800 2,591 158 out of 2,591 to receive 200 Shares 1.52%
1,000 2,740 168 out of 2,740 to receive 200 Shares 1.23%
1,200 1,396 86 out of 1,396 to receive 200 Shares 1.03%
1,400 836 52 out of 836 to receive 200 Shares 0.89%
1,600 794 50 out of 794 to receive 200 Shares 0.79%
1,800 776 49 out of 776 to receive 200 Shares 0.70%
2,000 9,968 630 out of 9,968 to receive 200 Shares 0.63%
3,000 1,864 118 out of 1,864 to receive 200 Shares 0.42%
4,000 2,265 145 out of 2,265 to receive 200 Shares 0.32%


--- page 11 ---
11
NO. OF SHARES
APPLIED FOR
NO. OF VALID
APPLICATIONS BASIS OF ALLOTMENT/BALLOT
APPROXIMATE
PERCENTAGE
ALLOTTED OF
THE TOTAL
NO. OF SHARES
APPLIED FOR
5,000 1,647 106 out of 1,647 to receive 200 Shares 0.26%
6,000 1,418 92 out of 1,418 to receive 200 Shares 0.22%
7,000 1,040 68 out of 1,040 to receive 200 Shares 0.19%
8,000 1,112 73 out of 1,112 to receive 200 Shares 0.16%
9,000 949 63 out of 949 to receive 200 Shares 0.15%
10,000 5,330 355 out of 5,330 to receive 200 Shares 0.13%
20,000 3,161 211 out of 3,161 to receive 200 Shares 0.07%
30,000 1,703 114 out of 1,703 to receive 200 Shares 0.04%
40,000 1,649 111 out of 1,649 to receive 200 Shares 0.03%
50,000 3,825 258 out of 3,825 to receive 200 Shares 0.03%
100,000 2,346 159 out of 2,346 to receive 200 Shares 0.01%
150,000 1,333 91 out of 1,333 to receive 200 Shares 0.01%
200,000 1,513 104 out of 1,513 to receive 200 Shares 0.01%

106,191 Total number of Pool A successful applicants: 6,635

POOL B
250,000 2,587 200 Shares plus 404 out of 2,587 to receive additional
 200 Shares
0.09%
300,000 908 200 Shares plus 142 out of 908 to receive additional
 200 Shares
0.08%
350,000 358 200 Shares plus 56 out of 358 to receive additional
 200 Shares
0.07%
400,000 326 200 Shares plus 51 out of 326 to receive additional
 200 Shares
0.06%
450,000 197 200 Shares plus 31 out of 197 to receive additional
 200 Shares
0.05%
500,000 158 200 Shares plus 25 out of 158 to receive additional
 200 Shares
0.05%
550,000 86 200 Shares plus 14 out of 86 to receive additional
 200 Shares
0.04%
600,000 171 200 Shares plus 29 out of 171 to receive additional
 200 Shares
0.04%
700,000 111 200 Shares plus 19 out of 111 to receive additional
 200 Shares
0.03%
800,000 120 200 Shares plus 21 out of 120 to receive additional
 200 Shares
0.03%


--- page 12 ---
12
NO. OF SHARES
APPLIED FOR
NO. OF VALID
APPLICATIONS BASIS OF ALLOTMENT/BALLOT
APPROXIMATE
PERCENTAGE
ALLOTTED OF
THE TOTAL
NO. OF SHARES
APPLIED FOR
900,000 50 200 Shares plus 9 out of 50 to receive additional
 200 Shares
0.03%
1,000,000 71 200 Shares plus 13 out of 71 to receive additional
 200 Shares
0.02%
1,100,000 37 200 Shares plus 7 out of 37 to receive additional
 200 Shares
0.02%
1,200,000 69 200 Shares plus 14 out of 69 to receive additional
 200 Shares
0.02%
1,327,000 454 200 Shares plus 97 out of 454 to receive additional
 200 Shares
0.02%

5,703 Total number of Pool B successful applicants: 5,703

As of the date of this announcement, the relevant subscription monies previously deposited in the
designated nominee accounts have been remitted back to the accounts of all HKSCC participants.
Investors should contact their relevant brokers for any inquiries.
COMPLIANCE WITH LISTING RULES AND GUIDANCE
The Directors confirm that, except for the Listing Rules that have been waived and/or in respect of
which consent has been obtained, the Company has complied with the Listing Rules and guidance
materials in relation to the placing, allotment and listing of the Company’s Shares.
The Directors confirm that, to the best of their knowledge, the consideration paid by the placees
or the public (as the case may be) directly or indirectly for each Offer Share subscribed for or
purchased by them was the same as the final Offer Price in addition to any brokerage, AFRC
transaction levy, SFC transaction levy and Stock Exchange trading fee payable.


--- page 13 ---
13
OTHERS/ADDITIONAL INFORMATION
Placing to connected clients with prior consents under paragraph 1C(1) of the Placing
Guidelines for Equity Securities pursuant to Appendix F1 of the Listing Rules
The Company has applied to the Stock Exchange for, and the Stock Exchange has granted, consents
under paragraph 1C(1) of the Placing Guidelines to permit allocation to connected clients pursuant
to the Placing Guidelines. The allocation of Offer Shares to such connected clients is in compliance
with all the conditions under the consents granted by the Stock Exchange. Details of the placement
to connected clients (including the cornerstone tranche and placing tranche) are set out below.
Connected Distributor Placee Relationship
Whether the Connected
Client will hold the
beneficial interests of the
Offer Shares on a non-
discretionary basis or
discretionary basis for
independent third parties
Number of Offer Shares
to be allocated to the
connected client
Approximate percentage
of Offer Shares allocated
to the connected client
Approximate percentage
of total issued share
capital after the Global
Offering
China International
Capital Corporation Hong
Kong Securities Limited
(“CICCHKS”)
Aoqin Heming
Note 1
Aoqin Heming is
managed by CICC Capital
as its general partner, and
both CICC Capital and
CICCHKS are wholly-
owned subsidiary of
China International
Capital Corporation
Limited (ፄ
ʮ̡). Aoqin
Heming is therefore
a connected client of
CICCHKS.
Discretionary basis 4,801,800 18.09% 2.33%
China Merchants
Securities (HK) Co.,
Limited (“ CMS”)
Bosera AM
Note 2
Bosera AM is a member
of the same group of
companies as CMS.
Discretionary basis 8,400 0.03% 0.004%
Notes:
1. Aoqin Heming intends to hold the Offer Shares on a discretionary basis on behalf of the
underlying investors (the “ Aoqin Heming Ultimate Clients ”), which are independent third
parties.
 To the best knowledge of Aoqin Heming is managed by CICC Capital Management Co., Ltd.
(ʮ̡ ) (“ CICC Capital ”) as its general partner, and CICC Capital is a
wholly-owned subsidiary of China International Capital Corporation Limited. Each of the
Aoqin Heming Ultimate Clients is an independent third party of the Company, its subsidiaries,
CICCHKS, Aoqin Heming and the companies which are members of the same group of
companies as CICCHKS.
2. Bosera AM will hold the Offer Shares on a discretionary basis on behalf of the underlying
investors. To the best knowledge of Bosera AM, each the underlying clients of Bosera AM is
an independent third party of Bosera AM, CMS and the companies which are members of the
same group of CMS.


--- page 14 ---
14
DISCLAIMERS
Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited and
Hong Kong Securities Clearing Company Limited take no responsibility for the contents of this
announcement, make no representation as to its accuracy or completeness and expressly disclaim
any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any
part of the contents of this announcement.
This announcement is not for release, publication, distribution, directly or indirectly, in or
into the United States (including its territories and possessions, any state of the United States
and the District of Columbia). This announcement does not, and is not intended to, constitute
or form a part of any offer to sell or solicitation to purchase or subscribe for any securities in
the United States. The Offer Shares have not been, and will not be, registered under the United
States Securities Act of 1933, as amended (the “ U.S. Securities Act ”) or securities law of any
state or other jurisdiction of the United States and may not be offered, sold, pledged or otherwise
transferred within the United States, except pursuant to an available exemption from, or in a
transaction not subject to, the registration requirements of the U.S. Securities Act. There will be
no public offer of the Offer Shares in the United States.
The Offer Shares are being offered and sold solely outside the United States in offshore
transactions in reliance on Regulation S under the U.S. Securities Act.
This announcement is for information purposes only and does not constitute an invitation or offer
to acquire, purchase or subscribe for securities. This announcement is not a prospectus. Potential
investors should read the Prospectus dated December 15, 2025 issued by QingSong Health
Corporation for detailed information about the Global Offering described below before deciding
whether or not to invest in the Shares thereby being offered.
* Potential investors of the Offer Shares should note that the Overall Coordinators (for themselves and on behalf of the
Hong Kong Underwriters) shall be entitled to terminate their obligations under the Hong Kong Underwriting Agreement
with immediate effect upon the occurrence of any of the events set out in the section headed “Underwriting — Hong Kong
Underwriting Arrangements — Hong Kong Public Offering — Grounds for Termination” in the Prospectus at any time prior to
8:00 a.m. (Hong Kong time) on the Listing Date (which is currently expected to be on Tuesday, December 23, 2025).
PUBLIC FLOAT AND FREE FLOAT
Immediately after the completion of the Global Offering, the total number of Shares held in
public hands represents approximately 37.94% of the total issued share capital of the Company,
based on the Offer Price of HK$22.68 per Share and the expected market value of the total issued
share capital of our Company being not exceeding HK$6 billion, thus will satisfy the minimum
percentage as prescribed under Rule 8.08(1) of the Listing Rules. Based on the Offer Price of
HK$22.68 per Share, the Company satisfies the free float requirement under Rule 8.08A of the
Listing Rules.


--- page 15 ---
15
The Directors confirm that, immediately following the completion of the Global Offering, (i)
no placee will, individually, be placed more than 10% of the enlarged issued share capital of
the Company immediately after the Global Offering; (ii) there will not be any new substantial
Shareholder immediately after the Global Offering; (iii) the three largest public shareholders of
the Company do not hold more than 50% of the shares in public hands at the time of the Listing
in compliance with Rules 8.08(3) and 8.24 of the Listing Rules; and (iv) there will be at least 300
Shareholders at the time of the Listing in compliance with Rule 8.08(2) of the Listing Rules.
COMMENCEMENT OF DEALINGS
The Share certificates will only become valid evidence of title at 8:00 a.m. on Tuesday, December
23, 2025 (Hong Kong time), provided that the Global Offering has become unconditional and the
right of termination described in the section headed “Underwriting — Hong Kong Underwriting
Arrangements — Hong Kong Public Offering — Grounds for Termination” in the Prospectus has
not been exercised. Investors who trade the Shares on the basis of publicly available allocation
details prior to the receipt of Share certificates or prior to the Share certificates becoming valid
evidence of title do so entirely at their own risk.
Assuming that the Global Offering becomes unconditional at or before 8:00 a.m. on Tuesday,
December 23, 2025 (Hong Kong time), it is expected that dealings in the Shares on the Stock
Exchange will commence at 9:00 a.m. on Tuesday, December 23, 2025 (Hong Kong time). The
Shares will be traded in board lots of 200 Shares each, and the stock code of the Shares will be
2661.
By order of the Board
QingSong Health Corporation
輕松健康集團
YANG Yin
Chairlady of the Board, Executive Director and Chief Executive Officer
Hong Kong, December 22, 2025
As of the date of this announcement, the board of directors of the Company named in the Prospectus comprises:
(i) Ms. YANG Yin and Ms. WANG Jing as executive Directors; (ii) Mr. ZHAO Yuping, Mr. ZHENG Kaihuan and Mr. WU Bin
as non-executive Directors; and (iii) Dr. WANG Xiaoyan, Mr. CHOW Yiu Ming and Mr. BAI Kun as proposed independent non-
executive Directors (effective upon Listing).
